Phase I study of F16IL2 antibody–cytokine fusion with very low‐dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation. (22nd February 2021) - Schliemann, Christoph; Kessler, Torsten; Berdel, Andrew F.; Hemmerle, Teresa; Angenendt, Linus; Altvater, Bianca; Rossig, Claudia; Mikesch, Jan‐Henrik; Lenz, Georg; Schäfers, Michael; Neri, Dario; Stelljes, Matthias; et al.